IMRX
Immuneering Corporation
$5.50
+$0.27(+5.16%)
25
Overall
40
Value
10
Tech
--
Quality
Market Cap
$254.23M
Volume
407.68K
52W Range
$1.10 - $10.08
Target Price
$17.00
Company Overview
| Mkt Cap | $254.23M | Price | $5.50 |
| Volume | 407.68K | Change | +5.16% |
| P/E Ratio | -4.2 | Open | $5.40 |
| Revenue | $19.2K | Prev Close | $5.23 |
| Net Income | $-61.0M | 52W Range | $1.10 - $10.08 |
| Div Yield | N/A | Target | $17.00 |
| Overall | 25 | Value | 40 |
| Quality | -- | Technical | 10 |
No chart data available
Latest News
Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and RxSight (RXST)
Howard Kim•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMRX | $5.50 | +5.2% | 407.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |